Evaluation of a questionnaire to assess selected infectious diseases and their risk factors : findings of a multicenter study.
dc.contributor.author | Sievers, Claudia | |
dc.contributor.author | Akmatov, Manas K | |
dc.contributor.author | Kreienbrock, Lothar | |
dc.contributor.author | Hille, Katja | |
dc.contributor.author | Ahrens, Wolfgang | |
dc.contributor.author | Günther, Kathrin | |
dc.contributor.author | Flesch-Janys, Dieter | |
dc.contributor.author | Obi, Nadia | |
dc.contributor.author | Michels, Karin B | |
dc.contributor.author | Fricke, Julia | |
dc.contributor.author | Greiser, Karin H | |
dc.contributor.author | Kaaks, Rudolf | |
dc.contributor.author | Peter, Hans-Hartmut | |
dc.contributor.author | Pessler, Frank | |
dc.contributor.author | Nieters, Alexandra | |
dc.contributor.author | Krause, Gerard | |
dc.date.accessioned | 2015-11-27T10:47:24Z | en |
dc.date.available | 2015-11-27T10:47:24Z | en |
dc.date.issued | 2014-11 | en |
dc.identifier.citation | Evaluation of a questionnaire to assess selected infectious diseases and their risk factors : findings of a multicenter study. 2014, 57 (11):1283-91 Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz | en |
dc.identifier.issn | 1437-1588 | en |
dc.identifier.pmid | 25300826 | en |
dc.identifier.doi | 10.1007/s00103-014-2052-y | en |
dc.identifier.uri | http://hdl.handle.net/10033/582782 | en |
dc.description.abstract | The risk to die from an infectious disease in Germany has been continuously decreasing over the last century. Since infections are, however, not only causes of death but risk factors for diseases like cardiovascular diseases, it is essential to monitor and analyze their prevalence and frequency, especially in consideration of the increased life expectancy. To gain more knowledge about infectious diseases as risk factors and their implications on the condition and change of the immune status, the German National Cohort (GNC), a population-based prospective cohort study, will recruit 200,000 subjects between 2014 and 2017. In Pretest 1, a feasibility study for the GNC, we evaluated a self-administered and self-report questionnaire on infectious diseases and on the use of health care facilities (hereinafter called "ID Screen") for feasibility and validity. | |
dc.language.iso | en | en |
dc.subject.mesh | Adult | en |
dc.subject.mesh | Aged | en |
dc.subject.mesh | Cohort Studies | en |
dc.subject.mesh | Communicable Diseases | en |
dc.subject.mesh | Feasibility Studies | en |
dc.subject.mesh | Germany | en |
dc.subject.mesh | Humans | en |
dc.subject.mesh | Immunocompromised Host | en |
dc.subject.mesh | Male | en |
dc.subject.mesh | Middle Aged | en |
dc.subject.mesh | Population Surveillance | en |
dc.subject.mesh | Prevalence | en |
dc.subject.mesh | Questionnaires | en |
dc.subject.mesh | Reproducibility of Results | en |
dc.subject.mesh | Risk Assessment | en |
dc.subject.mesh | Sensitivity and Specificity | en |
dc.subject.mesh | Young Adult | en |
dc.title | Evaluation of a questionnaire to assess selected infectious diseases and their risk factors : findings of a multicenter study. | en |
dc.type | Article | en |
dc.identifier.journal | Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz | en |
refterms.dateFOA | 2018-06-12T23:18:03Z | |
html.description.abstract | The risk to die from an infectious disease in Germany has been continuously decreasing over the last century. Since infections are, however, not only causes of death but risk factors for diseases like cardiovascular diseases, it is essential to monitor and analyze their prevalence and frequency, especially in consideration of the increased life expectancy. To gain more knowledge about infectious diseases as risk factors and their implications on the condition and change of the immune status, the German National Cohort (GNC), a population-based prospective cohort study, will recruit 200,000 subjects between 2014 and 2017. In Pretest 1, a feasibility study for the GNC, we evaluated a self-administered and self-report questionnaire on infectious diseases and on the use of health care facilities (hereinafter called "ID Screen") for feasibility and validity. |